3D-printed living neurons, wired to silicon, asked to do matrix math.
Intactis Bio
venture active confidence: Low status: Draft updated 2026-08-11
Summary
Salt Lake City-based Intactis Bio is wiring living neurons to custom silicon for experimental computing (company release). Its current impact is a tiny, replaceable lab demonstration; C* reflects how unusually worth reading the bio-computing bet is, not evidence that Intactis has moved the field.
Impact
The honest assessment is that Intactis has not yet produced impact in the world. What it has produced are early signals: in March 2026 the company announced a lab demonstration in which iPSC-derived neurons coupled to custom silicon hardware produced task-distinct activity patterns for arithmetic and language inputs, alongside a "biocomputation alpha" letting customers test AI/ML workflows against living-neuron biochips with silicon baselines.
The world-scale version of impact is not "brains in jars replace GPUs." It is a narrow but useful biological accelerator for tasks where adaptation, pattern separation, or energy efficiency matters more than deterministic digital logic. That bet remains unproven. Cortical Labs (Melbourne, with peer-reviewed DishBrain results), FinalSpark (Switzerland, with a commercial neuromorphic cloud), and Organic Robotics (Cornell) are all further along on adjacent paradigms.
What They Are Building
The product surface is an alpha biocomputation platform: customers submit silicon-trained models, Intactis converts them to biological inference format and runs them on living neural biochips, returning results alongside a silicon baseline. Phase 2 (planned 2027) expands to in-tissue training. The hard problems are exactly where you'd expect: keeping the tissue alive and consistent for commercial use, establishing reliable input/output protocols, and demonstrating that biological inference actually beats silicon on a real benchmark rather than a toy task.
For talent, this is a founding-team-plus-a-few-researchers environment: high leverage for someone with the right mix of neuroscience, bioelectronic engineering, wetlab automation, and ML; very high ambiguity, low career safety.
What They Need Now
The company site explicitly seeks computational neuroscientists, iPSC cell-culture talent, and AI/ML engineers — matching the alpha biocomputation stack. Broader needs still include bioelectronic engineers who can iterate on electrode and packaging interfaces, lab automation engineers, and anyone who can help close the gap between "interesting demonstration" and "reproducible, fairly-benchmarked product."
Who Could Help
Useful helpers include neural-engineering advisors, IP counsel familiar with the bioelectronics patent landscape, deep-tech investors comfortable with long timelines and binary outcomes, regulatory and bioethics advisors, and anyone with experience translating university tissue-culture work into manufacturable products. The Altitude Lab and Nucleus Institute communities are particularly close-by.
Utah Context
Intactis is a resident of Altitude Lab, the Recursion-spun incubator in Salt Lake City, and is technology and research spun out of the University of Utah. Utah's existing strengths around Recursion-style high-throughput biology, the U of U's biomedical engineering ecosystem, and the Wasatch Front's growing AI infrastructure make this a more credible place to attempt biohybrid compute than the company's sub-million-dollar capital base would suggest in isolation.
Evidence
Intactis Bio biocomputation alpha · https://www.intactis.bio/biocomputation-alpha
PR Newswire: lab-grown neurons say "Hello, World" · https://www.prnewswire.com/news-releases/lab-grown-neurons-say-hello-world-and-perform-matrix-math-on-automated-platform-intactis-bio-corp-raises-250k-from-nucleus-fund-302724652.html — source record
TechBuzz News: Intactis Bio and living neural tissue · https://www.techbuzznews.com/intactis-bio-pioneering-energy-efficient-ai-with-living-neural-tissue/
Utah Business: Utah AI momentum and Intactis Bio · https://www.utahbusiness.com/deal-dispatch/2026/03/03/deal-dispatch-utah-ai-momentum-deep-tech-jump-intactis-bio-nucleus-fund/
Open Questions
- The strongest technical claims are currently company-reported; independent peer-reviewed replication is essential before any of this can be taken at face value.
- The verified $250,000 Nucleus investment is pre-proof-of-concept territory (press release); the company will need much more funding to survive to its next technical phase.